patient monitoring, clinical trials, and microsampling
by Neoteryx, on Jan 24, 2019 4:24:00 AM
Remote patient monitoring (RPM) has resulted in great improvement in the experience of both clinicians and the patients. Doctors now have greater ability to easily access patient details, higher quality of healthcare delivery, and reduced risks for the patients. Innovations around RPM cover many health conditions in a wide geographical location.
The Role of Patient Monitoring in Clinical Trials
Patient monitoring has many advantages in the context of clinical trials. It has the capacity to improve the process by increasing patient retention and engagement, upping enrollment, and improving data collection. Here are some of the roles played by patient monitoring in clinical trials.
- Larger data volumes - Through mobile / remote collection of data, researchers are able to collect larger volumes of data. Having a wide range of results provides a large and reliable sample to test the medication in question. This also increases the accuracy since the sample covers a wide range of the population.
- Convenience - Most clinical tests require constant monitoring and therefore blood sampling now and then. There has been a need to find convenient ways of obtaining blood from the test subjects while causing as little inconvenience as possible. These are newer, more convenient methods emerging, such as microsampling, by which clinicians are able to obtain blood samples more conveniently, causing less pain.
- Timely visibility - Clinicians have better access to closer-to-real-time details of their patients through the patient monitoring mobile devices. This enables them to react in good time to the unexpected results of treatment. They are therefore able to know the side effects of the treatments and address them accordingly.
The Role of Microsampling
As already seen, microsampling offers convenience in many settings that require collection of blood or other biological fluids. In clinical trials, it can encourage better subject retention, create a potentially wider recruitment pool, and help facilitators spend more time and effort focused on getting results. It's economical, it's effective, and, as time goes on, it's going to be a growing part of the clinical trial conversation.